Understanding patient perspectives in the management of their muscle‐invasive bladder cancer
There are ongoing areas of unmet need in MIBC, including reducing time to definitive diagnosis and treatment, especially in women, and increasing multidisciplinary assessments prior to definitive surgery. Respondents were self-selected, had access to the BCAN website, and were highly educated, potentially limiting the generalizability of these results.
Authors
- Rick Bangs (ORCID: https://orcid.org/0000-0002-0706-8775)
- Deepro Chowdhury
- Stephanie Chisolm (ORCID: https://orcid.org/0000-0002-6194-3163)
- Matthew Kaag
- Andrea B. Apolo (ORCID: https://orcid.org/0000-0001-9409-1836)
- Manjula Maganti
- Srikala S. Sridhar (ORCID: https://orcid.org/0000-0002-6994-1285)
- Jason A. Efstathiou (ORCID: https://orcid.org/0000-0003-0996-0350)
- Gary D. Steinberg (ORCID: https://orcid.org/0000-0003-4469-0624)
- Di Jiang (ORCID: https://orcid.org/0000-0002-1950-2292)
- Eila Curlee Skinner
Institutions
- Rush University Medical Center (US)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Massachusetts General Hospital (US)
- Stanford Medicine (US)
- National Cancer Institute (US)
- Bladder Cancer Advocacy Network (US)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1111/bju.16695
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01